Sphingosine 1-Phosphate (S1P) Signaling and the Vasculature

Lysophospholipid Receptors: Signaling and Biochemistry

Volumn , Issue , 2013, Pages 313-347

  Waeber, Christian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

S1P and blood vessels, hormone transmitters; S1P on GpCR, in endothelium VSMC; S1P signaling, and vasculature; S1P synthesis and release; Vascular permeability inflammation

Indexed keywords

EID: 84886502309     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118531426.ch15     Document Type: Chapter

References (214)

1. Spiegel S, Milstien S. 2000. Sphingosine-1-phosphate: signaling inside and out. FEBS Lett 476:55-57.
2. Hla T, Maciag T. 1990. An abundant transcript induced in differentiating human endothelial cells encodes a polypeptide with structural similarities to Gprotein-coupled receptors. J Biol Chem 265:9308-9313.
3. Lee MJ, Van Brocklyn JR, Thangada S, Liu CH, Hand AR, et al. 1998. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 279:1552-1555.
4. Chun J, Goetzl EJ, Hla T, Igarashi Y, Lynch KR, et al. 2002. International Union of Pharmacology. XXXIV. Lysophospholipid receptor nomenclature. Pharmacol Rev 54:265-269.
5. Kimura T, Sato K, Kuwabara A, Tomura H, Ishiwara M, et al. 2001. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J Biol Chem 276:31780-31785.
6. Okajima F. 2002. Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 1582:132-137.
7. Pyne S, Pyne NJ. 2000. Sphingosine 1-phosphate signalling in mammalian cells. Biochem J 349:385-402.
8. Hänel P, Andreani P, Gräler MH. 2007. Erythrocytes store and release sphingosine 1-phosphate in blood. FASEB J 21:1202-1209.
9. Yatomi Y, Ruan F, Hakomori S, Igarashi Y. 1995. Sphingosine-1-phosphate: a platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 86:193-202.
10. Ito K, Anada Y, Tani M, Ikeda M, Sano T, et al. 2007. Lack of sphingosine 1-phosphate-degrading enzymes in erythrocytes. Biochem Biophys Res Commun 357:212-217.
11. Pappu R, Schwab SR, Cornelissen I, Pereira JP, Regard JB, et al. 2007. Promotion of lymphocyte egress into blood and lymph by distinct sources of sphingosine-1-phosphate. Science 316:295-298.
12. Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, et al. 2008. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102: 669-676.
13. Bode C, Sensken SC, Peest U, Beutel G, Thol F, et al. 2010. Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1-phosphate. J Cell Biochem 109:1232-1243.
14. Aoki S, Yatomi Y, Ohta M, Osada M, Kazama F, et al. 2005. Sphingosine 1-phosphate-related metabolism in the blood vessel. J Biochem (Tokyo) 138: 47-55.
15. Hla T, Venkataraman K, Michaud J. 2008. The vascular S1P gradient-cellular sources and biological significance. Biochim Biophys Acta 1781:477-482.
16. Zhao Y, Kalari SK, Usatyuk PV, Gorshkova I, He D, et al. 2007. Intracellular generation of sphingosine 1-phosphate in human lung endothelial cells: role of lipid phosphate phosphatase-1 and sphingosine kinase 1. J Biol Chem 282: 14165-14177.
17. Venkataraman K, Thangada S, Michaud J, Oo ML, Ai Y, et al. 2006. Extracellular export of sphingosine kinase-1a contributes to the vascular S1P gradient. Biochem J 397:461-471.
18. Clair T, Aoki J, Koh E, Bandle RW, Nam SW, et al. 2003. Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate. Cancer Res 63:5446-5453.
19. Murata N, Sato K, Kon J, Tomura H, Yanagita M, et al. 2000. Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions. Biochem J 352(Pt 3):809-815.
20. Bucki R, Kulakowska A, Byfield FJ, Zendzian-Piotrowska M, Baranowski M, et al. 2010. Plasma gelsolin modulates cellular response to sphingosine 1-phosphate. Am J Physiol Cell Physiol 299:C1516-C1523.
21. Goetzl EJ, An S. 1998. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J 12:1589-1598.
22. Nofer JR, van der Giet M, Tolle M, Wolinska I, von Wnuck Lipinski K, et al. 2004. HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3. J Clin Invest 113:569-581.
23. Kobayashi N, Kobayashi N, Yamaguchi A, Nishi T. 2009. Characterization of the ATP-dependent sphingosine 1-phosphate transporter in rat erythrocytes. J Biol Chem 284:21192-21200.
24. Yang L, Yatomi Y, Miura Y, Satoh K, Ozaki Y. 1999. Metabolism and functional effects of sphingolipids in blood cells. Br J Haematol 107:282-293.
25. Prieschl EE, Csonga R, Novotny V, Kikuchi GE, Baumruker T. 1999. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fc epsilon receptor I triggering. J Exp Med 190:1-8.
26. Mitra P, Oskeritzian CA, Payne SG, Beaven MA, Milstien S, Spiegel S. 2006. Role of ABCC1 in export of sphingosine-1-phosphate from mast cells. Proc Natl Acad Sci U S A 103:16394-16399.
27. Sato K, Malchinkhuu E, Horiuchi Y, Mogi C, Tomura H, et al. 2007. Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes. J Neurochem 103:2610-2619.
28. Kobayashi N, Nishi T, Hirata T, Kihara A, Sano T, et al. 2006. Sphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner. J Lipid Res 47:614-621.
29. Bouma HR, Kroese FG, Kok JW, Talaei F, Boerema AS, et al. 2011. Low body temperature governs the decline of circulating lymphocytes during hibernation through sphingosine-1-phosphate. Proc Natl Acad Sci U S A 108:2052-2057.
30. Takabe K, Kim RH, Allegood JC, Mitra P, Ramachandran S, et al. 2010. Estradiol induces export of sphingosine 1-phosphate from breast cancer cells via ABCC1 and ABCG2. J Biol Chem 285:10477-10486.
31. Hsiao SH, Constable PD, Smith GW, Haschek WM. 2005. Effects of exogenous sphinganine, sphingosine, and sphingosine-1-phosphate on relaxation and contraction of porcine thoracic aortic and pulmonary arterial rings. Toxicol Sci 86: 194-199.
32. Lee YM, Venkataraman K, Hwang SI, Han DK, Hla T. 2007. A novel method to quantify sphingosine 1-phosphate by immobilized metal affinity chromatography (IMAC). Prostaglandins Other Lipid Mediat 84:154-162.
33. Kawahara A, Nishi T, Hisano Y, Fukui H, Yamaguchi A, Mochizuki N. 2009. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science 323:524-527.
34. Peest U, Sensken SC, Andreani P, Hanel P, Van Veldhoven PP, Graler MH. 2008. S1P-lyase independent clearance of extracellular sphingosine 1-phosphate after dephosphorylation and cellular uptake. J Cell Biochem 104:756-772.
35. Schwab SR, Cyster JG. 2007. Finding a way out: lymphocyte egress from lymphoid organs. Nat Immunol 8:1295-1301.
36. Schwab SR, Pereira JP, Matloubian M, Xu Y, Huang Y, Cyster JG. 2005. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309:1735-1739.
37. Jiang X, Han X. 2006. Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach. J Lipid Res 47:1865-1873.
38. Murata N, Sato K, Kon J, Tomura H, Okajima F. 2000. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay. Anal Biochem 282: 115-120.
39. Blondeau N, Lai Y, Tyndall S, Popolo M, Topalkara K, et al. 2007. Distribution of sphingosine kinase activity and mRNA in rodent brain. J Neurochem 103: 509-517.
40. Anelli V, Bassi R, Tettamanti G, Viani P, Riboni L. 2005. Extracellular release of newly synthesized sphingosine-1-phosphate by cerebellar granule cells and astrocytes. J Neurochem 92:1204-1215.
41. Bassi R, Anelli V, Giussani P, Tettamanti G, Viani P, Riboni L. 2006. Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors. Glia 53:621-630.
42. Pyne NJ, Pyne S. 2010. Sphingosine 1-phosphate and cancer. Nat Rev Cancer 10:489-503.
43. Kim WS, Weickert CS, Garner B. 2008. Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem 104:1145-1166.
44. Fletcher JI, Haber M, Henderson MJ, Norris MD. 2010. ABC transporters in cancer: more than just drug efflux pumps. Nat Rev Cancer 10:147-156.
45. Kono M, Mi Y, Liu Y, Sasaki T, Allende ML, et al. 2004. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J Biol Chem 279:29367-29373.
46. Argraves KM, Wilkerson BA, Argraves WS, Fleming PA, Obeid LM, Drake CJ. 2004. Sphingosine-1-phosphate signaling promotes critical migratory events in vasculogenesis. J Biol Chem 279:50580-50590.
47. Battegay EJ. 1995. Angiogenesis: mechanistic insights, neovascular diseases, and therapeutic prospects. J Mol Med 73:333-346.
48. Ferrara N, Kerbel RS. 2005. Angiogenesis as a therapeutic target. Nature 438: 967-974.
49. Xia P, Wang L, Gamble JR, Vadas MA. 1999. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells. J Biol Chem 274:34499-34505.
50. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. 2001. Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem 276:7614-7620.
51. Igarashi J, Erwin PA, Dantas AP, Chen H, Michel T. 2003. VEGF induces S1P1 receptors in endothelial cells: implications for cross-talk between sphingolipid and growth factor receptors. Proc Natl Acad Sci U S A 100:10664-10669.
52. Mizugishi K, Yamashita T, Olivera A, Miller GF, Spiegel S, Proia RL. 2005. Essential role for sphingosine kinases in neural and vascular development. Mol Cell Biol 25:11113-11121.
53. Visentin B, Vekich JA, Sibbald BJ, Cavalli AL, Moreno KM, et al. 2006. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9:225-238.
54. Liu Y, Wada R, Yamashita T, Mi Y, Deng CX, et al. 2000. Edg-1, the G proteincoupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J Clin Invest 106:951-961.
55. Yonesu K, Kawase Y, Inoue T, Takagi N, Tsuchida J, et al. 2009. Involvement of sphingosine-1-phosphate and S1P1 in angiogenesis: analyses using a new S1P1 antagonist of non-sphingosine-1-phosphate analog. Biochem Pharmacol 77: 1011-1020.
56. Chae SS, Paik JH, Furneaux H, Hla T. 2004. Requirement for sphingosine 1-phosphate receptor-1 in tumor angiogenesis demonstrated by in vivo RNA interference. J Clin Invest 114:1082-1089.
57. Skoura A, Sanchez T, Claffey K, Mandala SM, Proia RL, Hla T. 2007. Essential role of sphingosine 1-phosphate receptor 2 in pathological angiogenesis of the mouse retina. J Clin Invest 117:2506-2516.
58. Vaupel P, Mayer A. 2007. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev 26:225-239.
59. Mazure NM, Brahimi-Horn MC, Berta MA, Benizri E, Bilton RL, et al. 2004. HIF-1: master and commander of the hypoxic world. A pharmacological approach to its regulation by siRNAs. Biochem Pharmacol 68:971-980.
60. Nakade Y, Banno Y, T-Koizumi K, Hagiwara K, Sobue S, et al. 2003. Regulation of sphingosine kinase 1 gene expression by protein kinase C in a human leukemia cell line, MEG-O1. Biochim Biophys Acta 1635:104-116.
61. Schwalm S, Doll F, Romer I, Bubnova S, Pfeilschifter J, Huwiler A. 2008. Sphingosine kinase-1 is a hypoxia-regulated gene that stimulates migration of human endothelial cells. Biochem Biophys Res Commun 368:1020-1025.
62. Anelli V, Gault CR, Cheng AB, Obeid LM. 2008. Sphingosine kinase 1 is upregulated during hypoxia in U87MG glioma cells. Role of hypoxia-inducible factors 1 and 2. J Biol Chem 283:3365-3375.
63. Ahmad M, Long JS, Pyne NJ, Pyne S. 2006. The effect of hypoxia on lipid phosphate receptor and sphingosine kinase expression and mitogen-activated protein kinase signaling in human pulmonary smooth muscle cells. Prostaglandins Other Lipid Mediat 79:278-286.
64. Ader I, Brizuela L, Bouquerel P, Malavaud B, Cuvillier O. 2008. Sphingosine kinase 1: a new modulator of hypoxia inducible factor 1alpha during hypoxia in human cancer cells. Cancer Res 68:8635-8642.
65. Schnitzer SE, Weigert A, Zhou J, Brune B. 2009. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells. Mol Cancer Res 7:393-401.
66. Oyama O, Sugimoto N, Qi X, Takuwa N, Mizugishi K, et al. 2008. The lysophospholipid mediator sphingosine-1-phosphate promotes angiogenesis in vivo in ischaemic hind limbs of mice. Cardiovasc Res 78:301-307.
67. Takuwa Y, Okamoto Y, Yoshioka K, Takuwa N. 2008. Sphingosine-1-phosphate signaling and biological activities in the cardiovascular system. Biochim Biophys Acta 1781:483-488.
68. Lee MJ, Thangada S, Claffey KP, Ancellin N, Liu CH, et al. 1999. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 99:301-312.
69. Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, et al. 2001. Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest 108:689-701.
70. Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, et al. 2009. Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Invest 119:1871-1879.
71. Singleton PA, Chatchavalvanich S, Fu P, Xing J, Birukova AA, et al. 2009. Aktmediated transactivation of the S1P1 receptor in caveolin-enriched microdomains regulates endothelial barrier enhancement by oxidized phospholipids. Circ Res 104:978-986.
72. Singleton PA, Dudek SM, Chiang ET, Garcia JG. 2005. Regulation of sphingosine 1-phosphate-induced endothelial cytoskeletal rearrangement and barrier enhancement by S1P1 receptor, PI3 kinase, Tiam1/Rac1, and alpha-actinin. FASEB J 19:1646-1656.
73. Singleton PA, Moreno-Vinasco L, Sammani S, Wanderling SL, Moss J, Garcia JG. 2007. Attenuation of vascular permeability by methylnaltrexone: role of mOP-R and S1P3 transactivation. Am J Respir Cell Mol Biol 37:222-231.
74. Zhang G, Xu S, Qian Y, He P. 2010. Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules. Am J Physiol Heart Circ Physiol 299:H1494-H1504.
75. Lee JF, Gordon S, Estrada R, Wang L, Siow DL, et al. 2009. Balance of S1P1 and S1P2 signaling regulates peripheral microvascular permeability in rat cremaster muscle vasculature. Am J Physiol Heart Circ Physiol 296:H33-H42.
76. Sanchez T, Skoura A, Wu MT, Casserly B, Harrington EO, Hla T. 2007. Induction of vascular permeability by the sphingosine-1-phosphate receptor-2 (S1P2R) and its downstream effectors ROCK and PTEN. Arterioscler Thromb Vasc Biol 27:1312-1318.
77. Foss FW, Jr., Snyder AH, Davis MD, Rouse M, Okusa MD, et al. 2007. Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtypeselective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg Med Chem 15:663-677.
78. Rosen H, Gonzalez-Cabrera P, Marsolais D, Cahalan S, Don AS, Sanna MG. 2008. Modulating tone: the overture of S1P receptor immunotherapeutics. Immunol Rev 223:221-235.
79. Sanna MG, Wang SK, Gonzalez-Cabrera PJ, Don A, Marsolais D, et al. 2006. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nat Chem Biol 2:434-441.
80. Sanchez T, Estrada-Hernandez T, Paik JH, Wu MT, Venkataraman K, et al. 2003. Phosphorylation and action of the immunomodulator FTY720 inhibits VEGFinduced vascular permeability. J Biol Chem 278:47281-47290.
81. Michel CC, Curry FE. 1999. Microvascular permeability. Physiol Rev 79: 703-761.
82. Mochizuki N. 2009. Vascular integrity mediated by vascular endothelial cadherin and regulated by sphingosine 1-phosphate and angiopoietin-1. Circ J 73:2183-2191.
83. Wang L, Dudek SM. 2009. Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res 77:39-45.
84. Finigan JH, Dudek SM, Singleton PA, Chiang ET, Jacobson JR, et al. 2005. Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation. J Biol Chem 280:17286-17293.
85. Singleton PA, Dudek SM, Ma SF, Garcia JG. 2006. Transactivation of sphingosine 1-phosphate receptors is essential for vascular barrier regulation. Novel role for hyaluronan and CD44 receptor family. J Biol Chem 281:34381-34393.
86. Hall A. 1998. Rho GTPases and the actin cytoskeleton. Science 279:509-514.
87. Vouret-Craviari V, Bourcier C, Boulter E, van Obberghen-Schilling E. 2002. Distinct signals via Rho GTPases and Src drive shape changes by thrombin and sphingosine-1-phosphate in endothelial cells. J Cell Sci 115:2475-2484.
88. Waschke J, Burger S, Curry FR, Drenckhahn D, Adamson RH. 2006. Activation of Rac-1 and Cdc42 stabilizes the microvascular endothelial barrier. Histochem Cell Biol 125:397-406.
89. Wojciak-Stothard B, Tsang LY, Paleolog E, Hall SM, Haworth SG. 2006. Rac1 and RhoA as regulators of endothelial phenotype and barrier function in hypoxiainduced neonatal pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 290:L1173-L1182.
90. Krump-Konvalinkova V, Yasuda S, Rubic T, Makarova N, Mages J, et al. 2005. Stable knock-down of the sphingosine 1-phosphate receptor S1P1 influences multiple functions of human endothelial cells. Arterioscler Thromb Vasc Biol 25: 546-552.
91. Lee JF, Zeng Q, Ozaki H, Wang L, Hand AR, et al. 2006. Dual roles of tight junction-associated protein, zonula occludens-1, in sphingosine 1-phosphatemediated endothelial chemotaxis and barrier integrity. J Biol Chem 281: 29190-29200.
92. Sastry SK, Burridge K. 2000. Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 261:25-36.
93. Shikata Y, Birukov KG, Garcia JG. 2003. S1P induces FA remodeling in human pulmonary endothelial cells: role of Rac, GIT1, FAK, and paxillin. J Appl Physiol 94:1193-1203.
94. Matloubian M, Lo CG, Cinamon G, Lesneski MJ, Xu Y, et al. 2004. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 427:355-360.
95. Goetzl EJ, Wang W, McGiffert C, Huang MC, Graler MH. 2004. Sphingosine 1-phosphate and its G protein-coupled receptors constitute a multifunctional immunoregulatory system. J Cell Biochem 92:1104-1114.
96. Rivera J, Proia RL, Olivera A. 2008. The alliance of sphingosine-1-phosphate and its receptors in immunity. Nat Rev Immunol 8:753-763.
97. Muller WA. 2011. Mechanisms of leukocyte transendothelial migration. Annu Rev Pathol 6:323-344.
98. Xia P, Gamble JR, Rye KA, Wang L, Hii CS, et al. 1998. Tumor necrosis factoralpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc Natl Acad Sci U S A 95:14196-14201.
99. Rizza C, Leitinger N, Yue J, Fischer DJ, Wang DA, et al. 1999. Lysophosphatidic acid as a regulator of endothelial/leukocyte interaction. Lab Invest 79:1227-1235.
100. Shimamura K, Takashiro Y, Akiyama N, Hirabayashi T, Murayama T. 2004. Expression of adhesion molecules by sphingosine 1-phosphate and histamine in endothelial cells. Eur J Pharmacol 486:141-150.
101. Lin CI, Chen CN, Lin PW, Lee H. 2007. Sphingosine 1-phosphate regulates inflammation-related genes in human endothelial cells through S1P1 and S1P3. Biochem Biophys Res Commun 355:895-901.
102. Chen XL, Grey JY, Thomas S, Qiu FH, Medford RM, et al. 2004. Sphingosine kinase-1 mediates TNF-alpha-induced MCP-1 gene expression in endothelial cells: upregulation by oscillatory flow. Am J Physiol Heart Circ Physiol 287: H1452-H1458.
103. Lee H, Lin CI, Liao JJ, Lee YW, Yang HY, et al. 2004. Lysophospholipids increase ICAM-1 expression in HUVEC through a Gi-and NF-kappaB-dependent mechanism. Am J Physiol Cell Physiol 287:C1657-C1666.
104. Miura Y, Yatomi Y, Ohmori T, Osada M, Ozaki Y. 2004. Independence of tumor necrosis factor-alpha-induced adhesion molecule expression from sphingosine 1-phosphate signaling in vascular endothelial cells. J Thromb Haemost 2:1019-1021.
105. Alewijnse AE, Peters SL. 2008. Sphingolipid signalling in the cardiovascular system: good, bad or both? Eur J Pharmacol 585:292-302.
106. Bolick DT, Srinivasan S, Kim KW, Hatley ME, Clemens JJ, et al. 2005. Sphingosine-1-phosphate prevents tumor necrosis factor-α-mediated monocyte adhesion to aortic endothelium in mice. Arterioscler Thromb Vasc Biol 25:976-981.
107. Kimura T, Tomura H, Mogi C, Kuwabara A, Ishiwara M, et al. 2006. Sphingosine 1-phosphate receptors mediate stimulatory and inhibitory signalings for expression of adhesion molecules in endothelial cells. Cell Signal 18:841-850.
108. Whetzel AM, Bolick DT, Srinivasan S, Macdonald TL, Morris MA, et al. 2006. Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ Res 99:731-739.
109. Theilmeier G, Schmidt C, Herrmann J, Keul P, Schafers M, et al. 2006. High-density lipoproteins and their constituent, sphingosine-1-phosphate, directly protect the heart against ischemia/reperfusion injury in vivo via the S1P3 lysophospholipid receptor. Circulation 114:1403-1409.
110. Wei Y, Yemisci M, Kim HH, Yung LM, Shin HK, et al. 2011. Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann Neurol 69: 119-129.
111. Hait NC, Oskeritzian CA, Paugh SW, Milstien S, Spiegel S. 2006. Sphingosine kinases, sphingosine 1-phosphate, apoptosis and diseases. Biochim Biophys Acta 1758:2016-2026.
112. Kang JS, Yoon YD, Han MH, Han SB, Lee K, et al. 2006. Glabridin suppresses intercellular adhesion molecule-1 expression in tumor necrosis factor-alphastimulated human umbilical vein endothelial cells by blocking sphingosine kinase pathway: implications of Akt, extracellular signal-regulated kinase, and nuclear factor-kappaB/Rel signaling pathways. Mol Pharmacol 69:941-949.
113. Kase H, Hattori Y, Jojima T, Okayasu T, Tomizawa A, et al. 2007. Globular adiponectin induces adhesion molecule expression through the sphingosine kinase pathway in vascular endothelial cells. Life Sci 81:939-943.
114. Aoki S, Yatomi Y, Shimosawa T, Yamashita H, Kitayama J, et al. 2007. The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5) beta(1) and alpha(v)beta(3). J Thromb Haemost 5:1292-1301.
115. Tani M, Kawakami A, Nagai M, Shimokado K, Kondo K, Yoshida M. 2007. Sphingosine 1-phosphate (S1P) inhibits monocyte-endothelial cell interaction by regulating of RhoA activity. FEBS Lett 581:4621-4626.
116. Maguire JJ, Davenport AP. 2005. Regulation of vascular reactivity by established and emerging GPCRs. Trends Pharmacol Sci 26:448-454.
117. Tosaka M, Okajima F, Hashiba Y, Saito N, Nagano T, et al. 2001. Sphingosine 1-phosphate contracts canine basilar arteries in vitro and in vivo: possible role in pathogenesis of cerebral vasospasm. Stroke 32:2913-2919.
118. Hopson KP, Truelove J, Chun J, Wang Y, Waeber C. 2011. S1P activates storeoperated calcium entry via receptor-and non-receptor-mediated pathways in vascular smooth muscle cells. Am J Physiol Cell Physiol 300:C919-C926.
119. Salomone S, Yoshimura S, Reuter U, Foley M, Thomas SS, et al. 2003. S1P3 receptors mediate the potent constriction of cerebral arteries by sphingosine-1-phosphate. Eur J Pharmacol 469:125-134.
120. Bischoff A, Czyborra P, Fetscher C, Meyer Zu Heringdorf D, Jakobs KH, Michel MC. 2000. Sphingosine-1-phosphate and sphingosylphosphorylcholine constrict renal and mesenteric microvessels in vitro. Br J Pharmacol 130:1871-1877.
121. Bischoff A, Czyborra P, Meyer Zu Heringdorf D, Jakobs KH, Michel MC. 2000. Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner. Br J Pharmacol 130:1878-1883.
122. Hedemann J, Fetscher C, Michel MC. 2004. Comparison of noradrenaline and lysosphingolipid-induced vasoconstriction in mouse and rat small mesenteric arteries. Auton Autacoid Pharmacol 24:77-85.
123. Hemmings DG. 2006. Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine. Naunyn Schmiedebergs Arch Pharmacol 373:18-29.
124. Hisano Y, Kobayashi N, Kawahara A, Yamaguchi A, Nishi T. 2011. The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720. J Biol Chem 286:1758-1766.
125. Murakami A, Takasugi H, Ohnuma S, Koide Y, Sakurai A, et al. 2010. Sphingosine 1-phosphate (S1P) regulates vascular contraction via S1P3 receptor: investigation based on a new S1P3 receptor antagonist. Mol Pharmacol 77:704-713.
126. Salomone S, Potts EM, Tyndall S, Ip PC, Chun J, et al. 2008. Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools. Br J Pharmacol 153:140-147.
127. Salomone S, Soydan G, Ip PC, Hopson KM, Waeber C. 2010. Vessel-specific role of sphingosine kinase 1 in the vasoconstriction of isolated basilar arteries. Pharmacol Res 62:465-474.
128. Sugiyama A, Yatomi Y, Ozaki Y, Hashimoto K. 2000. Sphingosine 1-phosphate induces sinus tachycardia and coronary vasoconstriction in the canine heart. Cardiovasc Res 46:119-125.
129. Thomas GD, Snetkov VA, Patel R, Leach RM, Aaronson PI, Ward JP. 2005. Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of non-store-operated Ca2+ entry. Cardiovasc Res 68:56-64.
130. Coussin F, Scott RH, Wise A, Nixon GF. 2002. Comparison of sphingosine 1-phosphate-induced intracellular signaling pathways in vascular smooth muscles: differential role in vasoconstriction. Circ Res 91:151-157.
131. Szczepaniak WS, Pitt BR, McVerry BJ. 2010. S1P2 receptor-dependent Rho-kinase activation mediates vasoconstriction in the murine pulmonary circulation induced by sphingosine 1-phosphate. Am J Physiol Lung Cell Mol Physiol 299:L137-L145.
132. Hemmings DG, Xu Y, Davidge ST. 2004. Sphingosine 1-phosphate-induced vasoconstriction is elevated in mesenteric resistance arteries from aged female rats. Br J Pharmacol 143:276-284.
133. Hemmings DG, Hudson NK, Halliday D, O'Hara M, Baker PN, et al. 2006. Sphingosine-1-phosphate acts via rho-associated kinase and nitric oxide to regulate human placental vascular tone. Biol Reprod 74:88-94.
134. Ancellin N, Hla T. 1999. Differential pharmacological properties and signal transduction of the sphingosine 1-phosphate receptors EDG-1, EDG-3, and EDG-5. J Biol Chem 274:18997-19002.
135. Lorenz JN, Arend LJ, Robitz R, Paul RJ, MacLennan AJ. 2007. Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 292:R440-R446.
136. Olivera A, Eisner C, Kitamura Y, Dillahunt S, Allende L, et al. 2010. Sphingosine kinase 1 and sphingosine-1-phosphate receptor 2 are vital to recovery from anaphylactic shock in mice. J Clin Invest 120:1429-1440.
137. Ohmori T, Yatomi Y, Osada M, Kazama F, Takafuta T, et al. 2003. Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2. Cardiovasc Res 58:170-177.
138. Salomone S, Waeber C. 2011. Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptormediated effects. Front Pharmacol 2:9. doi: 10.3389/fphar.2011.00009.
139. Kono M, Belyantseva IA, Skoura A, Frolenkov GI, Starost MF, et al. 2007. Deafness and stria vascularis defects in S1P2 receptor-null mice. J Biol Chem 282:10690-10696.
140. Peter BF, Lidington D, Harada A, Bolz HJ, Vogel L, et al. 2008. Role of sphingosine-1-phosphate phosphohydrolase 1 in the regulation of resistance artery tone. Circ Res 103:315-324.
141. Lidington D, Peter BF, Meissner A, Kroetsch JT, Pitson SM, et al. 2009. The phosphorylation motif at serine 225 governs the localization and function of sphingosine kinase 1 in resistance arteries. Arterioscler Thromb Vasc Biol 29:1916-1922.
142. Takuwa Y. 2002. Subtype-specific differential regulation of Rho family G proteins and cell migration by the Edg family sphingosine-1-phosphate receptors. Biochim Biophys Acta 1582:112-120.
143. Ghosh TK, Bian J, Gill DL. 1990. Intracellular calcium release mediated by sphingosine derivatives generated in cells. Science 248:1653-1656.
144. Ghosh TK, Bian J, Gill DL. 1994. Sphingosine 1-phosphate generated in the endoplasmic reticulum membrane activates release of stored calcium. J Biol Chem 269:22628-22635.
145. Mattie M, Brooker G, Spiegel S. 1994. Sphingosine-1-phosphate, a putative second messenger, mobilizes calcium from internal stores via an inositol trisphosphateindependent pathway. J Biol Chem 269:3181-3188.
146. Bolz SS, Vogel L, Sollinger D, Derwand R, Boer C, et al. 2003. Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase. Circulation 108:342-347.
147. Keller M, Lidington D, Vogel L, Peter BF, Sohn HY, et al. 2006. Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries. FASEB J 20:702-704.
148. Pyne S, Kong KC, Darroch PI. 2004. Lysophosphatidic acid and sphingosine 1-phosphate biology: the role of lipid phosphate phosphatases. Semin Cell Dev Biol 15:491-501.
149. Boujaoude LC, Bradshaw-Wilder C, Mao C, Cohn J, Ogretmen B, et al. 2001. Cystic fibrosis transmembrane regulator regulates uptake of sphingoid base phosphates and lysophosphatidic acid: modulation of cellular activity of sphingosine 1-phosphate. J Biol Chem 276:35258-35264.
150. Scherer EQ, Yang J, Canis M, Reimann K, Ivanov K, et al. 2010. Tumor necrosis factor-alpha enhances microvascular tone and reduces blood flow in the cochlea via enhanced sphingosine-1-phosphate signaling. Stroke 41:2618-2624.
151. Berdyshev EV, Gorshkova I, Usatyuk P, Kalari S, Zhao Y, et al. 2011. Intracellular S1P generation is essential for S1P-induced motility of human lung endothelial cells: role of sphingosine kinase 1 and S1P lyase. PLoS ONE 6:e16571.
152. Roviezzo F, Bucci M, Delisle C, Brancaleone V, Di Lorenzo A, et al. 2006. Essential requirement for sphingosine kinase activity in eNOS-dependent NO release and vasorelaxation. FASEB J 20:340-342.
153. Kim MY, Liang GH, Kim JA, Kim YJ, Oh S, Suh SH. 2006. Sphingosine-1-phosphate activates BKCa channels independently of G protein-coupled receptor in human endothelial cells. Am J Physiol Cell Physiol 290:C1000-C1008.
154. Mulders AC, Hendriks-Balk MC, Mathy MJ, Michel MC, Alewijnse AE, Peters SL. 2006. Sphingosine kinase-dependent activation of endothelial nitric oxide synthase by angiotensin II. Arterioscler Thromb Vasc Biol 26:2043-2048.
155. Mulders AC, Mathy MJ, Meyer Zu Heringdorf D, ter Braak M, Hajji N, et al. 2009. Activation of sphingosine kinase by muscarinic receptors enhances NO-mediated and attenuates EDHF-mediated vasorelaxation. Basic Res Cardiol 104:50-59.
156. Tolle M, Levkau B, Keul P, Brinkmann V, Giebing G, et al. 2005. Immunomodulator FTY720 Induces eNOS-dependent arterial vasodilatation via the lysophospholipid receptor S1P3. Circ Res 96:913-920.
157. Mair KM, Robinson E, Kane KA, Pyne S, Brett RR, et al. 2010. Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery. Br J Pharmacol 161:176-192.
158. Yonesu K, Nakamura T, Mizuno Y, Suzuki C, Nagayama T, et al. 2010. A novel sphingosine-1-phosphate receptor 1 antagonist prevents the proliferation and relaxation of vascular endothelial cells by sphingosine-1-phosphate. Biol Pharm Bull 33:1500-1505.
159. Igarashi J, Michel T. 2000. Agonist-modulated targeting of the EDG-1 receptor to plasmalemmal caveolae. eNOS activation by sphingosine 1-phosphate and the role of caveolin-1 in sphingolipid signal transduction. J Biol Chem 275: 32363-32370.
160. Igarashi J, Miyoshi M, Hashimoto T, Kubota Y, Kosaka H. 2007. Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. Br J Pharmacol 150:470-479.
161. Igarashi J, Bernier SG, Michel T. 2001. Sphingosine 1-phosphate and activation of endothelial nitric-oxide synthase. Differential regulation of Akt and MAP kinase pathways by EDG and bradykinin receptors in vascular endothelial cells. J Biol Chem 276:12420-12426.
162. Dantas AP, Igarashi J, Michel T. 2003. Sphingosine 1-phosphate and control of vascular tone. Am J Physiol Heart Circ Physiol 284:H2045-H2052.
163. Levine YC, Li GK, Michel T. 2007. Agonist-modulated regulation of AMPactivated protein kinase (AMPK) in endothelial cells. Evidence for an AMPK → Rac1 → Akt → endothelial nitric-oxide synthase pathway. J Biol Chem 282:20351-20364.
164. Jo E, Sanna MG, Gonzalez-Cabrera PJ, Thangada S, Tigyi G, et al. 2005. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem Biol 12: 703-715.
165. Wei SH, Rosen H, Matheu MP, Sanna MG, Wang SK, et al. 2005. Sphingosine 1-phosphate type 1 receptor agonism inhibits transendothelial migration of medullary T cells to lymphatic sinuses. Nat Immunol 6:1228-1235.
166. Rensen SS, Doevendans PA, van Eys GJ. 2007. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15:100-108.
167. Duling BR, Gore RW, Dacey RG, Jr., Damon DN. 1981. Methods for isolation, cannulation, and in vitro study of single microvessels. Am J Physiol 241: H108-H116.
168. Osol G, Halpern W. 1985. Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats. Am J Physiol 249:H914-H921.
169. Nielsen-Kudsk F, Poulsen B, Ryom C, Nielsen-Kudsk JE. 1986. A strain-gauge myograph for isometric measurements of tension in isolated small blood vessels and other muscle preparations. J Pharmacol Methods 16:215-225.
170. Mulvany MJ, Halpern W. 1977. Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 41:19-26.
171. Lazor R, Feihl F, Waeber B, Kucera P, Perret C. 1996. Endothelin-1 does not mediate the endothelium-dependent hypoxic contractions of small pulmonary arteries in rats. Chest 110:189-197.
172. Leach RM, Twort CH, Cameron IR, Ward JP. 1992. A comparison of the pharmacological and mechanical properties in vitro of large and small pulmonary arteries of the rat. Clin Sci (Lond) 82:55-62.
173. Mulvany MJ, Hansen OK, Aalkjaer C. 1978. Direct evidence that the greater contractility of resistance vessels in spontaneously hypertensive rats is associated with a narrowed lumen, a thickened media, and an increased number of smooth muscle cell layers. Circ Res 43:854-864.
174. Murphy RA, Herlihy JT, Megerman J. 1974. Force-generating capacity and contractile protein content of arterial smooth muscle. J Gen Physiol 64:691-705.
175. Nilsson H, Sjoblom N. 1985. Distension-dependent changes in noradrenaline sensitivity in small arteries from the rat. Acta Physiol Scand 125:429-435.
176. Park KM, Trucillo M, Serban N, Cohen RA, Bolotina VM. 2008. Role of iPLA2 and store-operated channels in agonist-induced Ca2+ influx and constriction in cerebral, mesenteric, and carotid arteries. Am J Physiol Heart Circ Physiol 294:H1183-H1187.
177. Schubert R, Wesselman JP, Nilsson H, Mulvany MJ. 1996. Noradrenaline-induced depolarization is smaller in isobaric compared to isometric preparations of rat mesenteric small arteries. Pflugers Arch 431:794-796.
178. Falloon BJ, Stephens N, Tulip JR, Heagerty AM. 1995. Comparison of small artery sensitivity and morphology in pressurized and wire-mounted preparations. Am J Physiol 268:H670-H678.
179. VanBavel E, Mulvany MJ. 1994. Role of wall tension in the vasoconstrictor response of cannulated rat mesenteric small arteries. J Physiol 477(Pt 1): 103-115.
180. Bareille R, Villars F, Remy M, Fernandez P, Bordenave L. 2003. Caution regarding the combined effects of extracellular matrices and nutrient media on cultured endothelial cells. Cell Biol Int 27:439-443.
181. Baudin B, Bruneel A, Bosselut N, Vaubourdolle M. 2007. A protocol for isolation and culture of human umbilical vein endothelial cells. Nat Protoc 2:481-485.
182. Kleinman HK, Cid MC. 2001. Preparation of endothelial cells. Curr Protoc Cell Biol Chapter 2:Unit 2.3.
183. Marin V, Kaplanski G, Gres S, Farnarier C, Bongrand P. 2001. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J Immunol Methods 254:183-190.
184. Terramani TT, Eton D, Bui PA, Wang Y, Weaver FA, Yu H. 2000. Human macrovascular endothelial cells: optimization of culture conditions. In Vitro Cell Dev Biol Anim 36:125-132.
185. van Beijnum JR, Rousch M, Castermans K, van der Linden E, Griffioen AW. 2008. Isolation of endothelial cells from fresh tissues. Nat Protoc 3:1085-1091.
186. Berra-Romani R, Mazzocco-Spezzia A, Pulina MV, Golovina VA. 2008. Ca2+ handling is altered when arterial myocytes progress from a contractile to a proliferative phenotype in culture. Am J Physiol Cell Physiol 295:C779-C790.
187. Golovina VA, Blaustein MP. 2006. Preparation of primary cultured mesenteric artery smooth muscle cells for fluorescent imaging and physiological studies. Nat Protoc 1:2681-2687.
188. Lu W, Ran P, Zhang D, Peng G, Li B, et al. 2010. Sildenafil inhibits chronically hypoxic upregulation of canonical transient receptor potential expression in rat pulmonary arterial smooth muscle. Am J Physiol Cell Physiol 298:C114-C123.
189. Ray JL, Leach R, Herbert JM, Benson M. 2001. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci 23:185-188.
190. Sreejayan N, Yang X. 2007. Isolation and functional studies of rat aortic smooth muscle cells. In Methods in Molecular Medicine. N. Sreejayan and J. Ren, eds. Totowa, NJ: Humana Press, pp. 283-292.
191. Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N. 2003. Angiogenesis assays: a critical overview. Clin Chem 49:32-40.
192. Murray J, ed. 2001. Angiogenesis Protocols, Vols. 48. Totowa, NJ: Humana Press.
193. Su SC, Mendoza EA, Kwak HI, Bayless KJ. 2008. Molecular profile of endothelial invasion of three-dimensional collagen matrices: insights into angiogenic sprout induction in wound healing. Am J Physiol Cell Physiol 295:C1215-C1229.
194. Ponce ML. 2009. Tube formation: an in vitro matrigel angiogenesis assay. Methods Mol Biol 467:183-188.
195. Arnaoutova I, Kleinman HK. 2010. In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc 5:628-635.
196. McGonigle S, Shifrin V. 2008. In vitro assay of angiogenesis: inhibition of capillary tube formation. Current Protocols in Pharmacology. 43:12.12.1-12.12.7.
197. Zhou Q, Kiosses WB, Liu J, Schimmel P. 2008. Tumor endothelial cell tube formation model for determining anti-angiogenic activity of a tRNA synthetase cytokine. Methods 44:190-195.
198. Goncharova EA, Lim P, Goncharov DA, Eszterhas A, Panettieri RA, Jr., Krymskaya VP. 2006b. Assays for in vitro monitoring of proliferation of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cells. Nat Protoc 1:2905-2908.
199. Mahabeleshwar G, Somanath P, Byzova T. 2006. Methods for isolation of endothelial and smooth muscle cells and in vitro proliferation assays. In Cardiovascular Disease: Methods and Protocols Volume 2. Q. Wang, ed. Totowa, NJ: Humana Press, pp. 197-208.
200. Goncharova EA, Goncharov DA, Krymskaya VP. 2006a. Assays for in vitro monitoring of human airway smooth muscle (ASM) and human pulmonary arterial vascular smooth muscle (VSM) cell migration. Nat Protoc 1:2933-2939.
201. Karakiulakis G, Papakonstantinou E, Roth M. 2000. Assay for cell migration and invasion of vascular smooth muscle cells. In Atherosclerosis: Experimental Methods and Protocols. A. Drew, ed. Totowa NJ: Humana Press, pp. 163-169.
202. Paik JH, Chae S, Lee MJ, Thangada S, Hla T. 2001. Sphingosine 1-phosphateinduced endothelial cell migration requires the expression of EDG-1 and EDG-3 receptors and Rho-dependent activation of alpha vbeta3-and beta1-containing integrins. J Biol Chem 276:11830-11837.
203. Soloviev D, Pluskota E, Plow E. 2006. Cell adhesion and migration assays. In Cardiovascular Disease: Methods and Protocols Volume 2. Q. Wang, ed. Totowa, NJ: Humana Press, pp. 267-278.
204. Boivin W, Granville D. 2007. Detection and quantification of apoptosis in the vasculature. In Vascular Biology Protocols. N. Sreejayan and J. Ren, eds. Totowa, NJ: Humana Press, pp. 181-195.
205. Hunter AL, Choy JC, Granville DJ. 2005. Detection of apoptosis in cardiovascular diseases. Methods Mol Med 112:277-289.
206. Oancea M, Mazumder S, Crosby M, Almasan A. 2006. Apoptosis assays. In Cardiovascular Disease: Methods and Protocols Volume 2. Q. Wang, ed. Totowa, NJ: Humana Press, pp. 279-290.
207. Zhang X, Parangi S. 2008. Quantification of vascular endothelial cell apoptosis in vivo. Methods Enzymol 446:287-292.
208. Weis SM. 2007. Evaluating integrin function in models of angiogenesis and vascular permeability. Methods Enzymol 426:505-528.
209. Weis SM. 2008. Chapter 5. Evaluating vascular leak in vivo. Methods Enzymol 444:99-114.
210. Garcia JG, Schaphorst KL, Shi S, Verin AD, Hart CM, et al. 1997. Mechanisms of ionomycin-induced endothelial cell barrier dysfunction. Am J Physiol 273: L172-L184.
211. Wojciak-Stothard B, Leiper J. 2008. Rho GTPases and hypoxia in pulmonary vascular endothelial cells. Methods Enzymol 439:267-283.
212. Kenakin T. 1998. Isolated blood vessel assays. Current Protocols in Pharmacology. 00:4.4.1-4.4.11.
213. Kramer K, Remie R. 2004. Measuring blood pressure in small laboratory animals. In Hypertension: Methods and Protocols. J. Fennell and A. Baker, eds. Totowa, NJ: Humana Press, pp. 51-62.
214. Spiers A, Padmanabhan N. 2004. A guide to wire myography. In Hypertension: Methods and Protocols. J. Fennell and A. Baker, eds. Totowa, NJ: Humana Press, pp. 91-104.